Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Kenneth Ataga, MD
Researcher Director
Division of Hematology/Oncology
University of Tennessee Health Science Center
956 Court Avenue
D324 Coleman Building
Memphis, Tennessee, United States
Dr. Ataga’s clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Pharmacologic Therapies for Sickle Cell Disease
Related Content
-
Elyse Mandell, MSN, RNCSElyse Mandell is the Nurse Director and ...
-
Hospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...
-
Barriers and Facilitators to Care for Individuals With Sickle Cell Disease in Central North Carolina: The Emergency ...Background: Sickle cell disease (SCD) i...
-
2019 WEPSCF Rockin’ the Red – 14th Annual FundraiserJoin us as we celebrate National Sickle ...
-
Increased acute care utilization in a prospective cohort of adults with sickle cell diseaseThe ESCAPED (Examining Sickle Cell Acute...
-
Riley Hospital for Children at Indiana University HealthThe Cancer & Blood Diseases Departme...
-
Laura De Castro, MDLaura M. De Castro MD, MHSc, is an Assoc...